Υδροκωδόνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Υδροκωδόνη" in Greek language version.

refsWebsite

Global rank Greek rank

25nih.gov

4^th place

19books.google.com

3^rd place

6^th place

16doi.org

2^nd place

3^rd place

5web.archive.org

1^st place

4archive.org

6^th place

5^th place

3drugs.com

399^th place

130^th place

3worldcat.org

5^th place

8^th place

2clincalc.com

3,912^th place

594^th place

2zenodo.org

621^st place

1,469^th place

2fda.gov

447^th place

368^th place

1medlineplus.gov

1,581^st place

474^th place

1wa.gov

2,121^st place

low place

1nytimes.com

7^th place

29^th place

1painphysicianjournal.com

low place

1aspetjournals.org

6,663^rd place

9,745^th place

1palliative.org

low place

archive.org

«Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: evidence from two parallel in vitro mouse models». Otolaryngol Head Neck Surg 142 (6): 814–9, 819.e1–2. June 2010. doi:10.1016/j.otohns.2010.01.010. PMID 20493351. https://archive.org/details/sim_otolaryngology-head-and-neck-surgery_2010-06_142_6/page/814.
«Analgesic use and the risk of hearing loss in men». Am. J. Med. 123 (3): 231–7. March 2010. doi:10.1016/j.amjmed.2009.08.006. PMID 20193831. PMC 2831770. https://archive.org/details/sim_american-journal-of-medicine_2010-03_123_3/page/231.
«Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors». J. Pharmacol. Exp. Ther. 308 (2): 547–54. February 2004. doi:10.1124/jpet.103.058602. PMID 14600248. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2004-02_308_2/page/547.
«Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype». Clin. Pharmacol. Ther. 91 (2): 321–6. February 2012. doi:10.1038/clpt.2011.287. PMID 22205192. PMC 3289963. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2012-02_91_2/page/321.

aspetjournals.org

jpet.aspetjournals.org

«Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception». J. Pharmacol. Exp. Ther. 274 (3): 1263–70. September 1995. PMID 7562497. http://jpet.aspetjournals.org/content/274/3/1263.short.

books.google.com

Bonewit-West, Kathy· Hunt, Sue A.· Applegate, Edith (2012). Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. σελ. 571. ISBN 9781455701506.
Jennifer A. Elliott· Howard S. Smith (19 Απριλίου 2016). Handbook of Acute Pain Management. CRC Press. σελίδες 79–. ISBN 978-1-4665-9635-1.
Gary S. Firestein· Ralph Budd· Sherine E. Gabriel· Iain B. McInnes· James R. O'Dell (21 Ιουνίου 2016). Kelley and Firestein's Textbook of Rheumatology. Elsevier Health Sciences. σελίδες 1081–. ISBN 978-0-323-41494-4.
Bruce A. Chabner· Dan L. Longo (8 Νοεμβρίου 2010). Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams & Wilkins. σελίδες 700–. ISBN 978-1-60547-431-1.
Shufeng Zhou (6 Απριλίου 2016). Cytochrome P450 2D6: Structure, Function, Regulation and Polymorphism. CRC Press. σελίδες 164–. ISBN 978-1-4665-9788-4.
Mellar P. Davis· Paul Glare (2005). Opioids in Cancer Pain. Oxford University Press. σελίδες 59–68. ISBN 978-0-19-852943-9.
Martin H. Bluth (16 Νοεμβρίου 2016). Toxicology and Drug Testing, An Issue of Clinics in Laboratory Medicine, E-Book. Elsevier Health Sciences. σελίδες 85–. ISBN 978-0-323-47795-6.
Howard S. Smith (21 Φεβρουαρίου 2013). Opioid Therapy in the 21st Century. OUP USA. σελίδες 68–. ISBN 978-0-19-984497-5.
Briggs, Gerald G.· Freeman, Roger K. (2011). Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins. σελ. 692. ISBN 9781608317080.
Fischer, Jnos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. σελ. 526. ISBN 9783527607495.
Stoker, H. Stephen (2012). General, Organic, and Biological Chemistry. Cengage Learning. σελ. 567. ISBN 9781133711285.
Mary Lynn McPherson (24 Αυγούστου 2009). Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing. ASHP. σελίδες 187–188. ISBN 978-1-58528-297-5.
Jan Odom-Forren· Cecil Drain (11 Φεβρουαρίου 2008). PeriAnesthesia Nursing: A Critical Care Approach. Elsevier Health Sciences. σελίδες 751–. ISBN 978-1-4377-2610-7.
Linda Skidmore-Roth (27 Ιουνίου 2013). Mosby's Drug Guide for Nursing Students, with 2014 Update. Elsevier Health Sciences. σελίδες 524–. ISBN 978-0-323-22268-6.
Nicholas J Talley· Brad Frankum (10 Φεβρουαρίου 2015). Essentials of Internal Medicine 3e. Elsevier Health Sciences. σελίδες 491–. ISBN 978-0-7295-8081-6.
Mary C. Brucker· Tekoa L. King (8 Σεπτεμβρίου 2015). Pharmacology for Women's Health. Jones & Bartlett Publishers. σελίδες 322–. ISBN 978-1-284-05748-5.
Steven B. Karch (9 Οκτωβρίου 2007). Pharmacokinetics and Pharmacodynamics of Abused Drugs. CRC Press. σελίδες 56–. ISBN 978-1-4200-5460-6.
Amitava Dasgupta· Jorge L. Sepulveda (22 Ιανουαρίου 2013). Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction. Newnes. σελίδες 239–. ISBN 978-0-12-415858-0.
Amitava Dasgupta· Loralie J. Langman (23 Απριλίου 2012). Pharmacogenomics of Alcohol and Drugs of Abuse. CRC Press. σελίδες 175–. ISBN 978-1-4398-5611-6.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Hydrocodone Bitartrate - Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers». Drug Alcohol Depend 101 (1–2): 107–14. April 2009. doi:10.1016/j.drugalcdep.2008.11.013. PMID 19118954. https://zenodo.org/record/896375.
«Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial». Acad Emerg Med 12 (4): 282–8. April 2005. doi:10.1197/j.aem.2004.12.005. PMID 15805317.
Vadivelu, Nalini; Schermer, Erika; Kodumudi, Gopal; Berger, Jack M. (2016). «The Clinical Applications of Extended-Release Abuse-Deterrent Opioids». CNS Drugs 30 (7): 637–646. doi:10.1007/s40263-016-0357-0. ISSN 1172-7047. PMID 27290716.
«Profound hearing loss associated with hydrocodone/acetaminophen abuse». Am J Otol 21 (2): 188–91. Mar 2000. doi:10.1016/S0196-0709(00)80007-1. PMID 10733182.
«Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: evidence from two parallel in vitro mouse models». Otolaryngol Head Neck Surg 142 (6): 814–9, 819.e1–2. June 2010. doi:10.1016/j.otohns.2010.01.010. PMID 20493351. https://archive.org/details/sim_otolaryngology-head-and-neck-surgery_2010-06_142_6/page/814.
«Analgesic use and the risk of hearing loss in men». Am. J. Med. 123 (3): 231–7. March 2010. doi:10.1016/j.amjmed.2009.08.006. PMID 20193831. PMC 2831770. https://archive.org/details/sim_american-journal-of-medicine_2010-03_123_3/page/231.
«Maternal treatment with opioid analgesics and risk for birth defects». Am. J. Obstet. Gynecol. 204 (4): 314.e1–11. April 2011. doi:10.1016/j.ajog.2010.12.039. PMID 21345403.
«Likeability and abuse liability of commonly prescribed opioids». J Med Toxicol 8 (4): 335–40. December 2012. doi:10.1007/s13181-012-0263-x. PMID 22992943.
«The serotonin syndrome». N. Engl. J. Med. 352 (23): 2454–6; author reply 2454–6. June 2005. doi:10.1056/NEJM200506093522320. PMID 15948273.
«Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors». J. Pharmacol. Exp. Ther. 308 (2): 547–54. February 2004. doi:10.1124/jpet.103.058602. PMID 14600248. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2004-02_308_2/page/547.
«Pharmacogenetics, drug-metabolizing enzymes, and clinical practice». Pharmacol. Rev. 58 (3): 521–90. September 2006. doi:10.1124/pr.58.3.6. PMID 16968950.
«Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype». Clin. Pharmacol. Ther. 91 (2): 321–6. February 2012. doi:10.1038/clpt.2011.287. PMID 22205192. PMC 3289963. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2012-02_91_2/page/321.
Navani, D. M.; Yoburn, B. C. (2013). «In Vivo Activity of Norhydrocodone: An Active Metabolite of Hydrocodone». Journal of Pharmacology and Experimental Therapeutics 347 (2): 497–505. doi:10.1124/jpet.113.207548. ISSN 1521-0103. PMID 23995596.
«Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions». Pediatrics 126 (4): e986–9. October 2010. doi:10.1542/peds.2009-1907. PMID 20837591.
«Pharmacogenomic considerations in opioid analgesia». Pharmgenomics Pers Med 5: 73–87. 2012. doi:10.2147/PGPM.S23422. PMID 23226064.
Mannich, C.; Löwenheim, Helene (1920). «Ueber zwei neue Reduktionsprodukte des Kodeins». Archiv der Pharmazie 258 (2–4): 295–316. doi:10.1002/ardp.19202580218. ISSN 0365-6233. https://zenodo.org/record/1424591.

drugs.com

«Hydrocodone Bitartrate Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists. Ανακτήθηκε στις 15 Απριλίου 2019.
«Hydrocodone Use During Pregnancy». Drugs.com. Ανακτήθηκε στις 15 Απριλίου 2019.
«Opioid (Narcotic Analgesics and Acetaminophen Systemic )». Αρχειοθετήθηκε από το πρωτότυπο στις 22 Μαρτίου 2014. Ανακτήθηκε στις 22 Μαρτίου 2014.

fda.gov

accessdata.fda.gov

«Drugs@FDA—Approval History: Hycodan». FDA. Ανακτήθηκε στις 7 Ιανουαρίου 2006.

fda.gov

«FDA Docket No. 2007N-0353, Drug Products Containing Hydrocodone; Enforcement Action Dates». FDA. Ανακτήθηκε στις 7 Ιανουαρίου 2006. See section I. B., DESI Review of Hydrocodone Products

medlineplus.gov

«Hydrocodone: MedlinePlus Drug Information». medlineplus.gov. Ανακτήθηκε στις 15 Απριλίου 2019.

nih.gov

ncbi.nlm.nih.gov

«Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers». Drug Alcohol Depend 101 (1–2): 107–14. April 2009. doi:10.1016/j.drugalcdep.2008.11.013. PMID 19118954. https://zenodo.org/record/896375.
«Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: a double-blind, randomized, controlled trial». Acad Emerg Med 12 (4): 282–8. April 2005. doi:10.1197/j.aem.2004.12.005. PMID 15805317.
«Pharmacology of opioids in the treatment of chronic pain syndromes». Pain Physician 14 (4): E343–60. 2011. PMID 21785485.
Vadivelu, Nalini; Schermer, Erika; Kodumudi, Gopal; Berger, Jack M. (2016). «The Clinical Applications of Extended-Release Abuse-Deterrent Opioids». CNS Drugs 30 (7): 637–646. doi:10.1007/s40263-016-0357-0. ISSN 1172-7047. PMID 27290716.
«Profound hearing loss associated with hydrocodone/acetaminophen abuse». Am J Otol 21 (2): 188–91. Mar 2000. doi:10.1016/S0196-0709(00)80007-1. PMID 10733182.
«Hydrocodone use and sensorineural hearing loss». Pain Physician 10 (3): 467–72. May 2007. PMID 17525781. Αρχειοθετήθηκε από το πρωτότυπο στις 23 July 2011. https://web.archive.org/web/20110723082234/http://www.painphysicianjournal.com/linkout_vw.php?issn=1533-3159&vol=10&page=467.
«Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: evidence from two parallel in vitro mouse models». Otolaryngol Head Neck Surg 142 (6): 814–9, 819.e1–2. June 2010. doi:10.1016/j.otohns.2010.01.010. PMID 20493351. https://archive.org/details/sim_otolaryngology-head-and-neck-surgery_2010-06_142_6/page/814.
«Analgesic use and the risk of hearing loss in men». Am. J. Med. 123 (3): 231–7. March 2010. doi:10.1016/j.amjmed.2009.08.006. PMID 20193831. PMC 2831770. https://archive.org/details/sim_american-journal-of-medicine_2010-03_123_3/page/231.
«Maternal treatment with opioid analgesics and risk for birth defects». Am. J. Obstet. Gynecol. 204 (4): 314.e1–11. April 2011. doi:10.1016/j.ajog.2010.12.039. PMID 21345403.
«Likeability and abuse liability of commonly prescribed opioids». J Med Toxicol 8 (4): 335–40. December 2012. doi:10.1007/s13181-012-0263-x. PMID 22992943.
«The serotonin syndrome». N. Engl. J. Med. 352 (23): 2454–6; author reply 2454–6. June 2005. doi:10.1056/NEJM200506093522320. PMID 15948273.
«Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors». J. Pharmacol. Exp. Ther. 308 (2): 547–54. February 2004. doi:10.1124/jpet.103.058602. PMID 14600248. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2004-02_308_2/page/547.
«Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception». J. Pharmacol. Exp. Ther. 274 (3): 1263–70. September 1995. PMID 7562497. http://jpet.aspetjournals.org/content/274/3/1263.short.
«Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability». J. Pharmacol. Exp. Ther. 281 (1): 103–8. April 1997. PMID 9103485.
«Pharmacogenetics, drug-metabolizing enzymes, and clinical practice». Pharmacol. Rev. 58 (3): 521–90. September 2006. doi:10.1124/pr.58.3.6. PMID 16968950.
«Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype». Clin. Pharmacol. Ther. 91 (2): 321–6. February 2012. doi:10.1038/clpt.2011.287. PMID 22205192. PMC 3289963. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2012-02_91_2/page/321.
Navani, D. M.; Yoburn, B. C. (2013). «In Vivo Activity of Norhydrocodone: An Active Metabolite of Hydrocodone». Journal of Pharmacology and Experimental Therapeutics 347 (2): 497–505. doi:10.1124/jpet.113.207548. ISSN 1521-0103. PMID 23995596.
«Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions». Pediatrics 126 (4): e986–9. October 2010. doi:10.1542/peds.2009-1907. PMID 20837591.
«Pharmacogenomic considerations in opioid analgesia». Pharmgenomics Pers Med 5: 73–87. 2012. doi:10.2147/PGPM.S23422. PMID 23226064.

pubmedcentral.nih.gov

«Analgesic use and the risk of hearing loss in men». Am. J. Med. 123 (3): 231–7. March 2010. doi:10.1016/j.amjmed.2009.08.006. PMID 20193831. PMC 2831770. https://archive.org/details/sim_american-journal-of-medicine_2010-03_123_3/page/231.
«Likeability and abuse liability of commonly prescribed opioids». J Med Toxicol 8 (4): 335–40. December 2012. doi:10.1007/s13181-012-0263-x. PMID 22992943.
«Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype». Clin. Pharmacol. Ther. 91 (2): 321–6. February 2012. doi:10.1038/clpt.2011.287. PMID 22205192. PMC 3289963. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2012-02_91_2/page/321.
«Pharmacogenomic considerations in opioid analgesia». Pharmgenomics Pers Med 5: 73–87. 2012. doi:10.2147/PGPM.S23422. PMID 23226064.

nlm.nih.gov

MedlinePlus; Drug Information: Hydrocodone. Last Revised—1 October 2008. Retrieved on 20 April 2013.

dailymed.nlm.nih.gov

«REPREXAIN (hydrocodone bitartrate, ibuprofen) tablet, film coated». dailymed.nlm.nih.gov. NIH. Ανακτήθηκε στις 27 Απριλίου 2013.

nytimes.com

«Making Some Painkillers Harder to Get». The New York Times. 21 February 2013. https://www.nytimes.com/2013/02/22/opinion/making-some-painkillers-harder-to-get.html. Ανακτήθηκε στις 15 April 2019.

painphysicianjournal.com

«Hydrocodone use and sensorineural hearing loss». Pain Physician 10 (3): 467–72. May 2007. PMID 17525781. Αρχειοθετήθηκε από το πρωτότυπο στις 23 July 2011. https://web.archive.org/web/20110723082234/http://www.painphysicianjournal.com/linkout_vw.php?issn=1533-3159&vol=10&page=467.

palliative.org

«Instructions for Mean Equivalent Daily Dose (MEDD)» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 27 Ιουλίου 2011. Ανακτήθηκε στις 22 Αυγούστου 2010.

wa.gov

agencymeddirectors.wa.gov

«Opioid Dose Calculator». Agency Medical Directors' Group. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Φεβρουαρίου 2016. Ανακτήθηκε στις 15 Απριλίου 2019.

web.archive.org

«Opioid Dose Calculator». Agency Medical Directors' Group. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Φεβρουαρίου 2016. Ανακτήθηκε στις 15 Απριλίου 2019.
«Hydrocodone Bitartrate - Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.
«Opioid (Narcotic Analgesics and Acetaminophen Systemic )». Αρχειοθετήθηκε από το πρωτότυπο στις 22 Μαρτίου 2014. Ανακτήθηκε στις 22 Μαρτίου 2014.
«Hydrocodone use and sensorineural hearing loss». Pain Physician 10 (3): 467–72. May 2007. PMID 17525781. Αρχειοθετήθηκε από το πρωτότυπο στις 23 July 2011. https://web.archive.org/web/20110723082234/http://www.painphysicianjournal.com/linkout_vw.php?issn=1533-3159&vol=10&page=467.
«Instructions for Mean Equivalent Daily Dose (MEDD)» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 27 Ιουλίου 2011. Ανακτήθηκε στις 22 Αυγούστου 2010.

worldcat.org

Vadivelu, Nalini; Schermer, Erika; Kodumudi, Gopal; Berger, Jack M. (2016). «The Clinical Applications of Extended-Release Abuse-Deterrent Opioids». CNS Drugs 30 (7): 637–646. doi:10.1007/s40263-016-0357-0. ISSN 1172-7047. PMID 27290716.
Navani, D. M.; Yoburn, B. C. (2013). «In Vivo Activity of Norhydrocodone: An Active Metabolite of Hydrocodone». Journal of Pharmacology and Experimental Therapeutics 347 (2): 497–505. doi:10.1124/jpet.113.207548. ISSN 1521-0103. PMID 23995596.
Mannich, C.; Löwenheim, Helene (1920). «Ueber zwei neue Reduktionsprodukte des Kodeins». Archiv der Pharmazie 258 (2–4): 295–316. doi:10.1002/ardp.19202580218. ISSN 0365-6233. https://zenodo.org/record/1424591.

zenodo.org

«Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers». Drug Alcohol Depend 101 (1–2): 107–14. April 2009. doi:10.1016/j.drugalcdep.2008.11.013. PMID 19118954. https://zenodo.org/record/896375.
Mannich, C.; Löwenheim, Helene (1920). «Ueber zwei neue Reduktionsprodukte des Kodeins». Archiv der Pharmazie 258 (2–4): 295–316. doi:10.1002/ardp.19202580218. ISSN 0365-6233. https://zenodo.org/record/1424591.